Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Lachesis Biosciences Limited manages a company patent portfolio in the Biotechnology & Pharmaceuticals technology area. The portfolio currently features 1 pending office action. This prosecution is being conducted by a lone distinct examiner and is situated within a lone distinct art unit. This suggests a very specific technical focus for the company's current active patent filings. The Biotechnology & Pharmaceuticals focus indicates that the company is likely developing new products or processes in the life sciences sector.
The busiest examiner for Lachesis Biosciences Limited is HIRAKIS, SOPHIA P, who is responsible for 1 busiest examiner pending office action. This accounts for the entirety of the company's pending office actions. For practitioners, this means that the prosecution outcome is highly dependent on this examiner's review. The presence of a lone distinct examiner and a lone distinct art unit indicates that the company's current active intellectual property is focused on a specific area, making the successful resolution of this 1 pending office action a key priority for the company's biotechnology portfolio.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Double-patenting + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| HIRAKIS, SOPHIA P | 1 | 56.1% | +73.5% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17999013 | METHODS OF TREATING OR PREVENTING ORGANOPHOSPHORUS POISONING | HIRAKIS, SOPHIA P | — |
| Art Unit | Apps |
|---|---|
| 1623 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17999013 | METHODS OF TREATING OR PREVENTING ORGANOPHOSPHORUS POISONING | HIRAKIS, SOPHIA P | 1623 | §103DP | Final Rejection | — | Pending | Nov 16, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial